Viking Global Investors’s BioMarin Pharmaceuticals BMRN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $676M | Buy |
12,288,611
+1,488,552
| +14% | +$81.8M | 1.95% | 14 |
|
|
2025
Q1 | $763M | Buy |
10,800,059
+289,509
| +3% | +$20.5M | 2.43% | 11 |
|
|
2024
Q4 | $691M | Buy |
10,510,550
+757,257
| +8% | +$49.8M | 2.24% | 16 |
|
|
2024
Q3 | $686M | Buy |
9,753,293
+2,689,729
| +38% | +$189M | 2.5% | 15 |
|
|
2024
Q2 | $582M | Buy |
7,063,564
+647,276
| +10% | +$53.3M | 2.24% | 18 |
|
|
2024
Q1 | $560M | Buy |
6,416,288
+1,526,834
| +31% | +$133M | 2.09% | 19 |
|
|
2023
Q4 | $471M | Buy |
4,889,454
+673,998
| +16% | +$65M | 1.73% | 20 |
|
|
2023
Q3 | $373M | Buy |
4,215,456
+58,671
| +1% | +$5.19M | 1.51% | 24 |
|
|
2023
Q2 | $360M | Buy |
4,156,785
+1,988,168
| +92% | +$172M | 1.48% | 26 |
|
|
2023
Q1 | $211M | Sell |
2,168,617
-3,105,003
| -59% | -$302M | 0.99% | 31 |
|
|
2022
Q4 | $546M | Buy |
5,273,620
+174,456
| +3% | +$18.1M | 2.73% | 13 |
|
|
2022
Q3 | $432M | Buy |
5,099,164
+46,571
| +0.9% | +$3.95M | 2% | 20 |
|
|
2022
Q2 | $419M | Buy |
5,052,593
+1,300,200
| +35% | +$108M | 1.92% | 24 |
|
|
2022
Q1 | $289M | Buy |
3,752,393
+882,446
| +31% | +$68M | 1.17% | 26 |
|
|
2021
Q4 | $254M | Buy |
+2,869,947
| New | +$254M | 0.73% | 41 |
|
|
2020
Q2 | – | Sell |
-1,453,625
| Closed | -$123M | – | 75 |
|
|
2020
Q1 | $123M | Sell |
1,453,625
-168,114
| -10% | -$14.2M | 0.64% | 40 |
|
|
2019
Q4 | $137M | Sell |
1,621,739
-1,436,365
| -47% | -$121M | 0.64% | 37 |
|
|
2019
Q3 | $206M | Buy |
3,058,104
+467,753
| +18% | +$31.5M | 1.07% | 26 |
|
|
2019
Q2 | $222M | Sell |
2,590,351
-2,538,558
| -49% | -$217M | 1% | 26 |
|
|
2019
Q1 | $456M | Buy |
5,128,909
+37,272
| +0.7% | +$3.31M | 2.61% | 12 |
|
|
2018
Q4 | $434M | Buy |
5,091,637
+962,696
| +23% | +$82M | 2.47% | 14 |
|
|
2018
Q3 | $400M | Buy |
4,128,941
+869,184
| +27% | +$84.3M | 2.22% | 13 |
|
|
2018
Q2 | $307M | Buy |
3,259,757
+1,577,291
| +94% | +$149M | 1.76% | 18 |
|
|
2018
Q1 | $136M | Buy |
+1,682,466
| New | +$136M | 0.82% | 30 |
|
|
2017
Q3 | – | Sell |
-259,656
| Closed | -$23.6M | – | 62 |
|
|
2017
Q2 | $23.6M | Sell |
259,656
-616,457
| -70% | -$56M | 0.16% | 52 |
|
|
2017
Q1 | $76.9M | Sell |
876,113
-522,344
| -37% | -$45.9M | 0.34% | 44 |
|
|
2016
Q4 | $116M | Buy |
1,398,457
+908,153
| +185% | +$75.2M | 0.53% | 36 |
|
|
2016
Q3 | $45.4M | Buy |
+490,304
| New | +$45.4M | 0.2% | 51 |
|
|
2016
Q2 | – | Sell |
-602,116
| Closed | -$49.7M | – | 56 |
|
|
2016
Q1 | $49.7M | Buy |
+602,116
| New | +$49.7M | 0.22% | 49 |
|